As shown in Figure 8, combined treatment with PTH and TAK-242 markedly decreased cerebral infarct volume (p < 0.01) and reduced neurological deficits (p < 0.05, Figure 8(C)). The gene discussed is PTH; the disease is cerebral infarction.